Performance Comparison: Applied UV And Competitors In Building Products Industry

Benzinga - by Benzinga Insights, Benzinga Staff Writer.

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Applied UV (NASDAQ:AUVI) in comparison to its major competitors within the Building Products industry. By analyzing critical financial metrics, market position, and growth potential, our objective is to provide valuable insights for investors and offer a deeper understanding of company's performance in the industry.

Applied UV Background Applied UV Inc is focused on the development and acquisition of technology that addresses infection control in the healthcare, hospitality, commercial and municipal markets. The company operates in three reportable segments: the design, manufacture, assembly and distribution of automated disinfecting systems for use in public spaces, hospitals and other healthcare facilities (Disinfectant segment) and the manufacture of fine mirrors specifically for the hospitality industry (Hospitality segment)and Corporate segment. It derives a majority of its revenue from the Hospitality segment.

th, td { padding: 8px; text-align: left; }

th { background-color: #293a5a; color: #fff; text-align: left; }

tr:nth-child(even) { background-color: #f2f4f8; }

tr:hover { background-color: #e1e4ea; }

td:nth-child(3), td:nth-child(5) { text-align: left; }

.dividend-amount { font-weight: bold; color: #0d6efd; }

.dividend-frequency { font-size: 12px; color: #6c757d; } By conducting a comprehensive analysis of Applied UV, the following trends become evident:

• With a Price to Earnings ratio of 0.02, which is 0.0x less than the industry average, the stock shows potential for growth at a reasonable price, making it an interesting consideration for market participants.

• With a Price to Book ratio of 0.2, significantly falling below the industry average by 0.11x, it suggests undervaluation and the possibility of untapped growth prospects.

• With a relatively low Price to Sales ratio of 0.02, which is 0.02x the industry average, the stock might be considered undervalued based on sales performance.

• The company has a lower Return on Equity (ROE) of -15.71%, which is 19.2% below the industry average. This indicates potential inefficiency in utilizing equity to generate profits, which could be attributed to various factors.

• With lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $-0 Million, which is -0.0x below the industry average, the company may face lower profitability or financial challenges.

• The gross profit of $0 Million is 0.0x below that of its industry, suggesting potential lower revenue after accounting for production costs.

• The company's revenue growth of 94.81% exceeds the industry average of -6.7%, indicating strong sales performance and market outperformance.

The debt-to-equity (D/E) ratio gauges the extent to which a company has financed its operations through debt relative to equity.

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.

When comparing Applied UV with its top 4 peers based on the Debt-to-Equity ratio, the following insights can be observed:

• Applied UV holds a middle position in terms of the debt-to-equity ratio compared to its top 4 peers.

• This indicates a balanced financial structure with a moderate level of debt and an appropriate reliance on equity financing with a debt-to-equity ratio of 0.76.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga